Clinical analysis evaluates tumor recurrence in non-muscle invasive bladder cancer, suggesting new prognostic methods.
Despite advances in surgical techniques, non-muscle invasive bladder cancer (NMIBC) is characterized by a high recurrence rate. Traditional prognostic systems do not always accurately assess the biological potential of the tumor, necessitating the search for additional molecular biomarkers. Aim. To evaluate the prog
No takes yet. Share an insight, caveat, or question.
Sh.Kh. et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: